A207 RIPK2 AND AMPK AS EMERGING THERAPEUTIC TARGETS FOR INFLAMMATORY BOWEL DISEASE

BACKGROUND: Persistent inflammation can trigger altered epigenetic, inflammation and bioenergetics states. Inflammatory bowel disease (IBD) is a heterogeneous disease with an abnormal inflammatory state and subsequent metabolic syndrome disorder. Current IBD therapeutics are directed to inhibit infl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Can Assoc Gastroenterol
Autori principali: Guo, Y, Dieleman, L A, Dooky, H, Joshi, H, Wine, E, Baksh, S
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Poster Presentation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043684/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.206
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi